new BindingDB logo
myBDB logout

27 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
25794791 13 Recent advances in the chemistry and biology of pyridopyrimidines.EBI Universit£ d'Orl£ans
25259627 36 Structural basis for inhibition of mycobacterial and human adenosine kinase by 7-substituted 7-(Het)aryl-7-deazaadenine ribonucleosides.EBI Academy of Sciences of the Czech Republic
15149648 32 A TOPS-MODE approach to predict adenosine kinase inhibition.EBI Vigo University
18077363 314 A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.EBI University of Oxford
15214773 76 Fragment-based drug discovery.EBI Sunesis Pharmaceuticals Inc.
8230132 7 New adenosine kinase inhibitors with oral antiinflammatory activity: synthesis and biological evaluation.EBI University of California
3351857 1 Synthesis, intramolecular hydrogen bonding, and biochemical studies of clitocine, a naturally occurring exocyclic amino nucleoside.EBI Nucleic Acid Research Institute
21711054 16 Synthesis and significant cytostatic activity of 7-hetaryl-7-deazaadenosines.EBI Academy of Sciences of the Czech Republic
21319802 51 Non-nucleoside inhibitors of human adenosine kinase: synthesis, molecular modeling, and biological studies.EBI Universita` di Siena
20055427 98 Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics.EBI Metabasis Therapeutics, Inc.
19348494 73 Fructose-1,6-bisphosphatase inhibitors. 1. Purine phosphonic acids as novel AMP mimics.EBI Metabasis Therapeutics, Inc.
17197188 110 4-amino-5-aryl-6-arylethynylpyrimidines: structure-activity relationships of non-nucleoside adenosine kinase inhibitors.EBI Abbott Laboratories
16302820 45 Adenosine kinase inhibitors. 6. Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides and related compounds.EBI Metabasis Therapeutics, Inc.
16190769 23 Adenosine kinase inhibitors. 5. Synthesis, enzyme inhibition, and analgesic activity of diaryl-erythro-furanosyltubercidin analogues.EBI Metabasis Therapeutics Inc.
15911258 45 Synthesis and biological evaluation of 6,7-disubstituted 4-aminopyrido[2,3-d]pyrimidines as adenosine kinase inhibitors.EBI Abbott Laboratories
15857145 22 Adenosine kinase inhibitors. 4. 6,8-Disubstituted purine nucleoside derivatives. Synthesis, conformation, and enzyme inhibition.EBI Metabasis Therapeutics, Inc.
15261263 14 Synthesis and biological evaluation of pteridine and pyrazolopyrimidine based adenosine kinase inhibitors.EBI Abbott Laboratories
15050645 35 Discovery and optimization of 2-aryl oxazolo-pyrimidines as adenosine kinase inhibitors using liquid phase parallel synthesis.EBI BAYER AG
14613327 46 5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel inhibitors of adenosine kinase.EBI Abbott Laboratories
14561094 20 Adenosine kinase inhibitors. 3. Synthesis, SAR, and antiinflammatory activity of a series of l-lyxofuranosyl nucleosides.EBI Metabasis Therapeutics, Inc.
12941329 30 Adenosine kinase inhibitors: polar 7-substitutent of pyridopyrimidine derivatives improving their locomotor selectivity.EBI Abbott Laboratories
11958989 60 QSAR study on adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues using the hansch approach.EBI Jadavpur University
11514141 16 Pyridopyrimidine analogues as novel adenosine kinase inhibitors.EBI Abbott Laboratories
11405650 42 Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor..EBI Abbott Laboratories
11123986 5 Design of adenosine kinase inhibitors from the NMR-based screening of fragments.EBI Abbott Laboratories
10956197 34 Adenosine kinase inhibitors. 2. Synthesis, enzyme inhibition, and antiseizure activity of diaryltubercidin analogues.EBI Metabasis Therapeutics Inc
10956196 39 Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues.EBI Metabasis Therapeutics Inc